F10 and atrial fibrillation: The Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) [23,24] was conducted in 14,264 patients of non-valvular atrial fibrillation.